OR WAIT null SECS
May 03, 2022
Inhalation formulations are complex, and empirical data are essential for realizing optimal solutions.
Advances in therapeutic modalities and an increase in molecular complexity have led to the need for an evolution in drug delivery approaches over the years.
Ongoing advances in technology and modeling techniques are helping to align all the objectives of both drug manufacturers and patients.
May 02, 2022
Recent trends in dissolution testing have led to increased use of data integrity solutions and more biorelevant testing techniques.
Partnering with an experienced service provider can help companies unlock the commercial potential of new therapeutic approaches.
Moderna has filed for emergency use authorization of its COVID-19 vaccine for use in young children six months to under six years of age.
What are the next steps for permanent authorization of COVID-19 vaccines, treatments, and diagnostics?
April 27, 2022
GeoVax has received a patent for its malaria vaccine from the US Patent and Trademark Office.
Pfizer and BioNTech have submitted an application for Emergency Use Authorization for a COVID-19 vaccine booster dose in young children.
April 25, 2022
EMA has granted Novo Nordisk a positive scientific opinion on human insulin with more flexible storage without refrigeration.